News

Following on from our inclusion in Sky News report on the need for new antibiotics we thought we'd show you some of our venom in action. This plate was dosed with one of our snake venoms specifically chosen by our scientists. The bacteria growing in a lawn are Staphylococcus albus which are clearly killed in a dose responsive matter by the venom. Work carried out at Canterbury Christ Church University.

We are excited to announce we are six years old. During those six years we have moved through three locations each time getting bigger and better. Now located in the amazing Discovery Park Community. We have shipped venoms to customers far and wide (USA, Europe, India and Australia). But most importantly we have facilitated work in a wide range of drug discovery programmes including new antibiotics, GPCR ligands, Pain therapeutics and Cancer biology. We have also gained a deep understanding of the venoms and the venomous animals (more publications to come). Looking forward we expect to further grow into the cosmetics and personal care fields as well as our global reach in pharmaceutical research.

Venomtech are proudly supporting World Pancreatic Cancer day in the best way we feel has the most impact. Interviewing potential PhD students for our joint project to combat this devastating disease with Canterbury Christ Church University CCCU news link. There are many challenges with Pancreatic cancer stemming from the lack of understanding of the disease, often a late diagnosis which leads to a very poor prognosis. In collaboration with the excellent scientists at Canterbury Christ Church University and their new laboratory in Discovery Park we will be building knowledge and discovering potential therapies for pancreatic cancer. Here is the Venomtech team proudly displaying our purple gloves in support of Pancreatic Cancer UK

Scorpions are an ancient group of arthropods who have evolved venom to subdue other invertebrates and even as an aphrodisiac in courtship. This potent cocktail of proteins peptides and other bio-molecules represents a wealth of new chemcial matter for drug discovery. As a result two of the top ten articles published in Toxicon are devoted to scorpion venoms as novel tools for drug discovery. Top of the list from Lourival Possani's lab details molecular scaffolds for anti cancer and antimicrobial compounds Paper 1 here. The other review from Peter Strongs team at Sheffield Hallam University focuses in on the antimicrobial peptides (AMP's) from these arachnids. In a world where nearly all our current antibiotics are all from fungal origins it is about time we investigate completely novel structures and mechanisms for controlling microbes in order to battle resistance paper 2 here.

in addition to these papers there is growing news of the tumour paint from the death stalker scorpion that is making it into clinical trials and veterinary medicine to allow surgeons to see cancer cells and therefore avoid damaging too much health brain tissue.

Venomtech have launched the last stage of their funding program with SyndicateRoom.

Venomtech^®, the United Kingdom’s only commercial venom supplier, and SyndicateRoom, one of the UK’s leading online equity crowdfunding platform, today announced the launch of Venomtech’s funding round. This partnership leverages the SyndicateRoom’s FCA regulated investment vehicle with the opportunity to be part of Venomtech’s groundbreaking approach for advancing drug discovery. The company’s unique natural venom libraries can solve the serious limitations of traditional chemical libraries for finding new, effective drugs.